In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DC Devices Inc.

Pressure-relieving implant for HF patients

This article was originally published in Start Up

Executive Summary

DC Devices Inc. has developed the first transcatheter, permanent implant for treating heart failure with preserved ejection fraction. The implant, placed in the atrial septum, creates a small, controlled shunt, allowing blood to move from the higher-pressure left atrium to the lower pressure, more compliant right atrium; this serves to reduce left atrial pressure and relieve HF symptoms, without compromising cardiac output.



Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts